Clinical trial
Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine…
NCT00303602 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00303602 |
|---|---|
| Title | Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height) |
| Official title | BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS) |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Sublingual orally disintegrating olanzapine (SODO), Oral olanzapine |
| Enrollment | 149 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Mar 17, 2006 |
| Last update posted | Jun 10, 2009 |
| Countries | Canada, Mexico, Netherlands, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: